Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
Gabriela Gautier-Vargas, Clément Baldacini, Iliès Benotmane, Nicolas Keller, Peggy Perrin, Bruno Moulin, Sophie Caillard
Topics & Concepts
TocilizumabImmunosuppressionMedicineCoronavirus disease 2019 (COVID-19)Cytokine release syndromeKidney transplantationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCytokineKidneyTransplantationKidney transplantImmunologyInternal medicineVirologyRheumatoid arthritisDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Muscle and Compartmental Disorders